01Impact factor
Impact factor of Current Drug Safety (2026)
The impact factor shown here is the 2-year mean citedness: citations received in a year by the papers Current Drug Safety published in the two previous years, divided by the number of those papers. That is the same formula as the Journal Impact Factor, calculated by ScholarsColab. The journal is listed in JCR 2024, so it also has an official Journal Impact Factor published by Clarivate, which can differ because it counts citations from Web of Science journals only.
Rank in its subject categories
- Pharmacology & Pharmacyrank 265 of 371 journals
Ranks here compare journals of the same Web of Science category in our data by 2-year citedness; they are not the official JCR rank.
Quartile of Current Drug Safety
A journal's quartile (Q1 to Q4) is its position within a subject category: Q1 is the top quarter. The official quartiles are published by Clarivate in Journal Citation Reports (by Journal Impact Factor, in Web of Science categories) and by Scimago as the SJR quartile (in Scopus categories). Current Drug Safety is listed in JCR 2024, so its JCR quartile is in Journal Citation Reports. It is indexed in Scopus, so Scimago shows its SJR quartile. ScholarsColab does not show a quartile until it can show the official one; the impact factor and rank above are calculated from open data.
Citations and papers per year
Is your paper a fit for Current Drug Safety?
Most desk rejections come from a scope mismatch. Compare your title and abstract with what this journal really publishes. Free, no sign-up, about 2 minutes.
Check my paper for this journalOr find journals that fit my paper
02Review time
Review time of Current Drug Safety
Each paper took a different time. The green box holds the middle half of the papers and the dark line is the median; the whiskers reach the fastest 10% and the slowest 10%. Plan with the whole spread, not only the median.
Half of the research articles Current Drug Safety published between Oct 2024 and Aug 2026 were accepted within 96 days of submission, and the middle half took between 71 and 125 days. This time includes peer review and any revision rounds. Papers that were rejected are not counted, because only published papers carry these dates.
In Pharmacology & Pharmacy, Current Drug Safety ranks 58 of 157 journals by review time (1 = fastest). See the fastest-review journals in Pharmacology & Pharmacy →
Need a faster review? Current Drug Safety takes a median of 96 days; the fastest journals in Pharmacology & Pharmacy take 3.
APC waivers and discounts for Current Drug Safety
Bentham Science: 50% discount for corresponding authors in countries on Bentham's low-income list.
03Retractions
Retractions and research integrity at Current Drug Safety
Most common reasons (a retraction can have several):
Current Drug Safety has 1 retracted paper on record, the latest in Aug 2024. A retraction count is not a verdict on a journal: large journals publish more and journals that investigate actively retract more. The trend and the reasons tell you more than the number.
04Funders
Who funds research published in Current Drug Safety
Funders named most often
A high share of funded papers usually means the journal is a common choice for grant-supported work in its field. If your funder pays article processing charges, or your country qualifies for a waiver, check what applies to your author team with the free APC waiver checker.
05Indexing
Indexing of Current Drug Safety
- ISSN
- 1574-8863
- eISSN
- 2212-3911
- Publisher
- Bentham Science Publishers all its journals →
- Country
- Netherlands
- Language
- English
- Scopus source type
- Journal
- Web of Science categories
- Pharmacology & Pharmacy
From the indexing lists used on ScholarsColab, updated 1 March 2026. Indexing can change: confirm on the Web of Science Master Journal List or the Scopus source list before submitting. Official Journal Impact Factors and JCR quartiles are published by Clarivate; the impact factor on this page is calculated by ScholarsColab (see how the impact factor works).
Each link opens the official record for this journal, searched by its ISSN where we have one.
06How to submit
How to submit to Current Drug Safety
- Read the guide for authors. It sets the article types, word limit, reference style and file format that Current Drug Safety accepts. You find it on the official website of the journal, usually under "For authors" or "Submit".
- Format to the journal's style. Check whether it wants a Word file, a LaTeX file or a PDF for the first submission, and follow its reference style; many journals accept any clear format at first and ask for their style only after acceptance. If the language or structure needs work first, manuscript editing by a PhD editor in your field is priced by word count (see the editing cost guide).
- Check the fit. Read the aims and scope and a few recent issues; papers outside the scope are the most common reason for a desk rejection. The Journal Finder shows journals that published the closest work.
- Check the fee. Current Drug Safety is not a fully open access journal, so authors usually pay nothing unless they choose open access for their article or the journal charges page or colour fees. The guide for authors states the current charges.
- Check your manuscript before you submit. The free Submission Readiness Check asks the seven questions our reviewers ask in every audit and takes about 2 minutes.
07Reviewer comments
Reviewer comments and rejection reasons for Current Drug Safety
No reviewer or editor comments have been shared for this journal yet. Did you submit here? Help other researchers by sharing the comments you received, anonymously.
Share reviewer comments for this journal →Across the reviewer comments researchers have shared with us, the points raised most often are figures, tables and equations (21%), literature and references (12%) and novelty and contribution (10%). Before you submit to Current Drug Safety, a Manuscript Audit by a PhD reviewer in your area checks your paper against exactly these points.
Audit my paper before I submit →Worried about the English? Manuscript editing by editors in your subject: see the price →
Not sure yet? Check if your paper is ready for this journal: free, no AI, under 5 seconds08Same subject
Pharmacology & Pharmacy journals with a similar impact factor*
The journals next to Current Drug Safety when the 354 journals of Pharmacology & Pharmacy in our data are ranked by impact factor*:
| Rank | Journal | Impact factor* | Indexing | Open access |
|---|---|---|---|---|
| 261 | Revista Brasileira de Farmacognosia | 1.55 | SCIE | Subscription |
| 262 | Turkish Journal of Pharmaceutical Sciences | 1.54 | ESCI | Some open access |
| 263 | Journal of Pharmacy And Bioallied Sciences | 1.54 | ESCI | Fully open access |
| 264 | Clinical Pharmacology in Drug Development | 1.53 | SCIE | Subscription |
| 266 | Revista Española de Quimioterapia | 1.50 | SCIE | Fully open access |
| 267 | Endocrine Metabolic & Immune Disorders - Drug Targets | 1.50 | SCIE | Subscription |
| 268 | American Journal of Health-System Pharmacy | 1.48 | SCIE | Subscription |
| 269 | Iranian journal of pharmaceutical research | 1.42 | SCIE | Subscription |
*Impact factor calculated by ScholarsColab (2-year citedness), not the official Clarivate value.
Is Current Drug Safety right for your paper? Find the right journal
Paste your title, keywords or abstract. See the journals that published the closest papers, with indexing, impact factor, review time and APC.
No AI or language model is used. Your words are matched against the titles of 157,375 real published journal papers, by our mentors and by other researchers (shown without names); journals are ranked by how many closely matching papers they published. Indexing comes from the SCIE, SSCI, AHCI, ESCI, Scopus and JCR 2024 lists, matched by journal name; the impact factor is calculated by ScholarsColab, not the official Clarivate value, and no quartile is shown until the official JCR or SJR quartile can be; review time is the median days from submission to acceptance (not every publisher publishes these dates). Always check a journal’s scope and current indexing before submitting.
09Questions
Frequently asked questions
How long is the review time of Current Drug Safety?
Based on 162 research articles Current Drug Safety published from Oct 2024 to Aug 2026, the median time from submission to acceptance was 96 days, and half of them were accepted between 71 and 125 days. After acceptance, papers appeared online after a median of 220 days. Data updated October 2026. Individual papers can take longer, especially with major revisions.
What is the impact factor of Current Drug Safety?
Based on ScholarsColab citation data (October 2026), the 2-year impact factor of Current Drug Safety is 1.51: papers it published in the two previous years were cited 1.51 times on average in a year. The journal is listed in JCR 2024, so Clarivate also publishes an official Journal Impact Factor, which can differ.
What is the h-index of Current Drug Safety?
The h-index of Current Drug Safety is 51 (October 2026): 51 of its papers have each been cited at least 51 times. Its i10-index is 378.
What is the quartile of Current Drug Safety?
A journal's quartile (Q1 to Q4) is its position within a subject category: Q1 is the top quarter. The official quartiles are published by Clarivate in Journal Citation Reports (by Journal Impact Factor, in Web of Science categories) and by Scimago as the SJR quartile (in Scopus categories). Current Drug Safety is listed in JCR 2024, so its JCR quartile is in Journal Citation Reports. It is indexed in Scopus, so Scimago shows its SJR quartile. ScholarsColab does not show a quartile until it can show the official one; the impact factor and rank above are calculated from open data.
Is Current Drug Safety indexed in Scopus?
Yes. Current Drug Safety appears in the Scopus list, according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.
Is Current Drug Safety an SCIE journal?
Current Drug Safety is listed in ESCI of the Web of Science Core Collection, but not in SCIE, according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.
Is Current Drug Safety in Journal Citation Reports (JCR)?
Yes. Current Drug Safety is listed in JCR 2024, so it has a Journal Impact Factor. For the current impact factor and quartile, check Journal Citation Reports.
Does Current Drug Safety offer an APC waiver?
Current Drug Safety follows the policy of Bentham Science: 50% discount for corresponding authors in countries on Bentham's low-income list. Only the corresponding author's affiliation counts. Co-authors from other countries do not change the waiver. Rules verified 27 October 2026; confirm on the publisher's page.
Has Current Drug Safety retracted papers?
Yes. 1 retracted paper are on record for Current Drug Safety, 1 of them in the last 10 years; the most common reasons are cites retracted work. A retraction count alone is not a verdict on a journal; look at the trend and the reasons. Data updated October 2026.
Who funds research published in Current Drug Safety?
5% of 174 recent research articles in Current Drug Safety name a funder; the funders named most often are Agencia Nacional de Investigación y Desarrollo, São Paulo Research Foundation, Mazandaran University of Medical Sciences.
Popular journals
- The Lancet
- Nature
- Science
- PLoS ONE
- Scientific Reports
- Journal of the American Chemical Society
- Organic Letters
- Biophysical Journal
- Cancer Research
- Frontiers in Immunology
- Applied Physics Letters
- Journal of Bacteriology
- European journal of cancer
- Materials
- Investigative Ophthalmology and Visual Science
- Journal of Dairy Science
- Construction and Building Materials
- Journal of Physical Chemistry A
- Angewandte Chemie
- Journal of Physical Chemistry C
Browse all journals: indexing, impact factor and reviewer comments →